CVRS / Corindus Vascular Robotics, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

CVRS / Corindus Vascular Robotics, Inc. 15-12B - - NOTICE OF TERMINATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37406 CORINDUS VASCULAR ROBOTICS, INC. (Exact name of registrant as spec

CVRS / Corindus Vascular Robotics, Inc. AW - - WITHDRAWAL OF AMENDMENT TO A REGISTRATION STATEMENT

Corindus Vascular Robotics, Inc. 309 Waverley Oaks Road, Suite 105 Waltham, MA 02452 November 1, 2019 VIA EDGAR Securities and Exchange Commission, Division of Corporation Finance, 100 F Street, N.E. Washington, D.C. 20549 Re: Corindus Vascular Robotics, Inc. Request for Withdrawal Pursuant to Rule 477 of Post-Effective Amendment to Registration Statement No. 333-176581 Ladies and Gentlemen: In ac

CVRS / Corindus Vascular Robotics, Inc. S-8 POS - - POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. S-8 POS - - POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. S-8 POS - - POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. S-8 POS - - POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. POS AM - - POST-EFFECTIVE AMENDMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. POS AM - - POST-EFFECTIVE AMENDMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. POS AM - - POST-EFFECTIVE AMENDMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. POS AM - - POST-EFFECTIVE AMENDMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. POS AM - - POST-EFFECTIVE AMENDMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. / Hudson Executive Capital LP - SCHEDULE 13D (AMENDMENT NO. 3) Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

CVRS / Corindus Vascular Robotics, Inc. / KONINKLIJKE PHILIPS NV - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4)* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Sec

CVRS / Corindus Vascular Robotics, Inc. / HealthCor Management, L.P. - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 2) Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 218730109 (CUSIP Number) HealthCor Management

CVRS / Corindus Vascular Robotics, Inc. POS AM - - POST-EFFECTIVE AMENDMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

CVRS / Corindus Vascular Robotics, Inc. S-8 POS - - POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on October 29, 2019 Registration No.

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES NYSE American LLC hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on November 11, 2019, pursuant to the provisions of Rule 12d2-2 (a).

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact name of registrant as specified in its charter) Delaware 001-37406 30-0687898 (State of Incorporation) (Commission File No.) (

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION CORINDUS VASCULAR ROBOTICS, INC.

Corindus Vascular Robotics, Inc. 8-K Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CORINDUS VASCULAR ROBOTICS, INC. FIRST: The name of the corporation is Corindus Vascular Robotics, Inc. (the “Corporation”). SECOND: The address of the Corporation’s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, Delaware 19801. T

AMENDED AND RESTATED BYLAWS CORINDUS VASCULAR ROBOTICS, INC. ARTICLE I

Corindus Vascular Robotics, Inc. 8-K Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF CORINDUS VASCULAR ROBOTICS, INC. ARTICLE I Offices Section 1.01 Registered Office. The registered office of the Corporation shall be established and maintained at the office of The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, and said corporation shall be the Reg

Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of registrant as specified in charter) Delaware 001-37406 30-0687898 (State of Incorporation) (Commission File No.) (IRS

CORINDUS VASCULAR ROBOTICS, INC. STOCKHOLDERS APPROVE ACQUISITION BY SIEMENS HEALTHINEERS

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 99.1 FOR IMMEDIATE RELEASE CORINDUS VASCULAR ROBOTICS, INC. STOCKHOLDERS APPROVE ACQUISITION BY SIEMENS HEALTHINEERS WALTHAM, MA, October 25, 2019 – At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the adoption of the Agreement and Plan of Merger (the “Merger Agreem

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Comm

CVRS / Corindus Vascular Robotics, Inc. DEFM14A - - DEFINITIVE PROXY STATEMENT RELATING TO MERGER OR ACQUISITION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Stat

Other Events

8-K 1 cvrs-8k083019.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware 000-37406 30-0687898 (State or Othe

CVRS / Corindus Vascular Robotics, Inc. PREM14A - - PRELIMINARY PROXY STATEMENT

PREM14A 1 cvrs-prem14a082719.htm PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission On

CVRS / Corindus Vascular Robotics, Inc. / SMITH ROBERT J - AMENDMENT TO FORM SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Amendment No. 1) (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a)) UNDER THE SECURITIES EXCHANGE ACT OF 1934 CORINDUS VASCULAR ROBOTICS, INC. (Name of Issuer) Common Stock, $0.0001 Par Value Per Share (Title of Class of

CORINDUS VASCULAR ROBOTICS, INC. 10-Q

10-Q 1 cvrs-10q063019.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Co

[Signature Pages Follow]

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 10.3 August 7, 2019 Mark Toland c/o Corindus Vascular Robotics, Inc. 309 Waverley Oaks Road, Suite 105 Waltham, MA 02452 Re: Transaction Bonus Dear Mark: Reference is made to that certain Agreement and Plan of Merger (the “Merger Agreement”), by and among Siemens Medical Solutions USA, Inc. (“Parent”), Corpus Merger, Inc. (“Merger Sub”), and Corindus Va

CORINDUS VASCULAR ROBOTICS ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY SIEMENS HEALTHINEERS -- Corindus Stockholders to Receive $4.28 Per Share -- -- All-Cash Transaction Valued at Approximately $1.1 Billion --

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 99.2 CORINDUS VASCULAR ROBOTICS ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY SIEMENS HEALTHINEERS - Corindus Stockholders to Receive $4.28 Per Share - - All-Cash Transaction Valued at Approximately $1.1 Billion - WALTHAM, MA, August 8, 2019 – Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of precision vascular robotics, today

AGREEMENT AND PLAN OF MERGER by and among SIEMENS MEDICAL SOLUTIONS USA, INC., CORPUS MERGER, INC., CORINDUS VASCULAR ROBOTICS, INC. Dated as of August 7, 2019 TABLE OF CONTENTS

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 2.1 EXECUTION COPY AGREEMENT AND PLAN OF MERGER by and among SIEMENS MEDICAL SOLUTIONS USA, INC., CORPUS MERGER, INC., and CORINDUS VASCULAR ROBOTICS, INC. Dated as of August 7, 2019 TABLE OF CONTENTS Page ARTICLE I THE MERGER Section 1.1 The Merger 6 Section 1.2 The Closing 7 Section 1.3 Effective Time 7 Section 1.4 Certificate of Incorporation; Bylaws

Corindus Q2 2019 Conference Call

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 99.1 Corindus Q2 2019 Conference Call Judy DiClemente Thank you, . Welcome to Corindus Vascular Robotics’ second quarter 2019 earnings call. This is Judy DiClemente, investor relations for Corindus. With me on today’s call are Corindus’ Chief Executive Officer, Mark Toland, and Chief Financial Officer, David Long. This morning, the Company issued two pr

Siemens Healthineers AG c/o Siemens Healthcare GmbH, Att. Dagmar Munani, SHS LC, and Marco Stülpner, SHS M&A Karlheinz-Kaske-Str. 5, 91052 Erlangen, Germany Email: [email protected]

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 10.2 Siemens Healthineers AG, SHS BF, Karlheinz-Kaske-Str. 5, 91052 Erlangen Name Dr. Jochen Schmitz Abteilung SHS BF Telefon +49 (9131) 84-8390 Corindus Vascular Robotics, Inc. E-Mail [email protected] Att. Jeffrey C. Lightcap 309 Waverley Oaks Road, Suite 105 Datum 7 August 2019 Waltham, MA 02452 United States of America Letter o

VOTING AND SUPPORT AGREEMENT

EX-10.1 3 ex10-1.htm VOTING AND SUPPORT AGREEMENT CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 10.1 EXECUTION COPY VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of August 7, 2019, is entered into by and between Siemens Medical Solutions USA, Inc., a Delaware corporation (“Parent”), and the undersigned entities listed on the signature pages hereto (each

Corindus Reports Second Quarter 2019 Results Corindus announced today a definitive agreement to be acquired by Siemens Healthineers for approximately $1.1 billion, or $4.28 per share, in an all-cash transaction Second quarter revenue of $4.6 million

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Reports Second Quarter 2019 Results Corindus announced today a definitive agreement to be acquired by Siemens Healthineers for approximately $1.1 billion, or $4.28 per share, in an all-cash transaction Second quarter revenue of $4.6 million reflects increasing adoption and utilization in U.S. and abroad WALTHAM, Mass., August 8, 2019 – Cor

Results of Operations and Financial Condition, Financial Statements and Exhibits

8-K 1 cvrs-8k080819.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in Charter) Delaware 000-37406 30-0687898 (State or Other

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 3, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Commi

Corindus Vascular Robotics, Inc. 14,384,840 Shares of Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-230541 PROSPECTUS Corindus Vascular Robotics, Inc. 14,384,840 Shares of Common Stock This prospectus relates to the offering and resale by the selling stockholders identified herein, including their pledgees, donees, transferees, assigns or other successors-in-interest, of up to 14,384,840 shares of common stock of Corindus Vascular Robotics, I

CORINDUS VASCULAR ROBOTICS, INC. 10-Q

cvrs-10q033119.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-374

Corindus Reports First Quarter 2019 Results Eleven purchase orders for CorPath GRX Systems as adoption grows

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Reports First Quarter 2019 Results Eleven purchase orders for CorPath GRX Systems as adoption grows WALTHAM, Mass.—May 7, 2019 - Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2019. Recent Financial Highlights

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Commi

CVRS / Corindus Vascular Robotics, Inc. CORRESP - -

CORRESP 1 filename1.htm Corindus Vascular Robotics, Inc. 309 Waverley Oaks Road, Suite 105 Waltham, MA 02452 May 6, 2019 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Corindus Vascular Robotics, Inc. Registration Statement on Form S-3 Filed Wednesday, March 27, 2019 File No. 333-230541 Request for Accelerati

CVRS / Corindus Vascular Robotics, Inc. / INTEGRATED CORE STRATEGIES (US) LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 CORINDUS VASCULAR ROBOTICS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 218730109 (CUSIP Number) APRIL 22, 2019 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursua

CVRS / Corindus Vascular Robotics, Inc. DEFINITIVE PROXY STATEMENT

DEF 14A 1 cvrs-def14a050319.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the

Corindus Vascular Robotics, Inc. S-3

As filed with the Securities and Exchange Commission on March 27, 2019 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Corindus Vascular Robotics, Inc. (Exact name of registrant as specified in its charter) Delaware EIN 30-0687898 (State of Incorporation) (IRS Employer Identification No.) 309 Waverley

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 21, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Co

Letter from Ernst &Young LLP dated March 26, 2019.

Corindus Vascular Robotics, Inc. 8-K Exhibit 16.1 March 26, 2019 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated March 26, 2019, of Corindus Vascular Robotics, Inc. and are in agreement with the statements contained in Item 4.01 (a) paragraphs two, three, and four therein. We have no basis to agree or disagre

CVRS / Corindus Vascular Robotics, Inc. / HealthCor Management, L.P. - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 1) Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 218730109 (CUSIP Number) HealthCor Management

2

Corindus Vascular Robotics, Inc. 10-K Exhibit 10.17 Corindus Vascular Robotics, Inc. Director Compensation Policy as Amended and Restated Effective February 1, 2019 I. Overview The Board of Directors (the “Board”) of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) has approved the following Director Compensation Policy (the “Policy”) to provide an inducement to attract and retain th

Corindus Vascular Robotics, Inc. 10-K

Corindus Vascular Robotics, Inc. 10-K Exhibit 4.5

Corindus Vascular Robotics, Inc. 10-K

Corindus Vascular Robotics, Inc. 10-K Exhibit 4.4

60

Corindus Vascular Robotics, Inc. 10-K Exhibit 21 Subsidiaries of the registrant ● Corindus, Inc., a Delaware corporation and wholly-owned subsidiary ● Corindus Security Corporation, a Delaware corporation and wholly-owned subsidiary 60

EMPLOYMENT AGREEMENT

Corindus Vascular Robotics, Inc. 10-K Exhibit 10.12 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into on June 15, 2018 by and between Corindus Vascular Robotics, Inc., a Delaware corporation with its principal office in Waltham, Massachusetts (the “Company”), and Douglas Teany (the “Executive”). Any reference herein to “Corindus” shall mean Corindus, Inc., a wholly-

Corindus Vascular Robotics, Inc. 10-K

cvrs-10k123118.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37406 CORINDUS VASCULAR ROBOTICS, INC. (Exact name of Regi

Form of Securities Purchase Agreement, dated March 12, 2019, by and among the Company and the purchasers named therein

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 12, 2019, by and between Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and each Purchaser identified on Exhibit A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

First Amendment to Loan and Security Agreement, dated March 14, 2019, by and among the Company and the parties named therein

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.3 FIRST Amendment to Loan and security agreement (TERM LOAN) This First Amendment to Loan and Security Agreement (Term Loan) (this “Amendment”) is entered into this 14th day of March, 2019 among (a) SILICON VALLEY BANK, a California corporation (“SVB”), as collateral agent (in such capacity, the “Collateral Agent”), (b) the lenders listed on Schedule

Form of Warrant to Purchase Common Stock, dated March 14, 2019

Corindus Vascular Robotics, Inc. 8-K Exhibit 4.1 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION

Form of Registration Rights Agreement, dated March 12, 2019, by and among the Company and the signatories thereto

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is dated as of March 12, 2019, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto. Recitals This Agreement is made pursuant to the Securities Purchase Agreement (the “Purchase Agreement”), dated

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 EIN 30-0687898 (State of Incorporation) (Commission File Numb

REGISTRATION RIGHTS AGREEMENT

Exhibit 10 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is dated as of March 12, 2019, by and among Corindus Vascular Robotics, Inc.

CVRS / Corindus Vascular Robotics, Inc. / Hudson Executive Capital LP - SCHEDULE 13 D AMENDMENT NO. 2 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

SECURITIES PURCHASE AGREEMENT

Exhibit 9 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 12, 2019, by and between Corindus Vascular Robotics, Inc.

CVRS / Corindus Vascular Robotics, Inc. / KONINKLIJKE PHILIPS NV - SC 13D/A Activist Investment

SC 13D/A 1 d722821dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Pe

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 cvrs-8k031219.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 12, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or O

Corindus Reports Fourth Quarter and Full Year 2018 Results Submitted Neurovascular Indication Marking Important Step toward Addressing Stroke Market; Raised $19.8 Million to Fund Ongoing Innovation

ex99-1.htm Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Reports Fourth Quarter and Full Year 2018 Results Submitted Neurovascular Indication Marking Important Step toward Addressing Stroke Market; Raised $19.8 Million to Fund Ongoing Innovation WALTHAM, Mass.—March 12, 2019 - Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, t

Corindus Vascular Robotics Announces Closing of Private Placement for $15 Million

EX-99.1 4 ex99-1.htm PRESS RELEASE Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 For Immediate Release Corindus Vascular Robotics Announces Closing of Private Placement for $15 Million WALTHAM, MA – February 26, 2019 – Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced the execution of a priv

SECURITIES PURCHASE AGREEMENT

EX-10.1 2 ex10-1.htm FORM OF SECURITIES PURCHASE AGREEMENT Corindus Vascular Robotics, Inc. 8-K Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 26, 2019, by and between Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and each Purchaser identified on Exhibit A hereto (each, including its successors an

REGISTRATION RIGHTS AGREEMENT

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is dated as of February 26, 2019, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto. Recitals This Agreement is made pursuant to the Securities Purchase Agreement (the “Purchase Agreement”), dat

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 EIN 30-0687898 (State of Incorporation) (Commission File N

Corindus Vascular Robotics, Inc. 8-K

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) January 2019 Forward Looking Statements This presentation contains “forward - looking statements” (as such term is defined in Section 27 A of the Securities Act of 1933 , as amended, and Section 21 E of the Securities Exchange Act of 1934 , as amended), and information relating to the co

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 4, 2019 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (C

Corindus Vascular Robotics, Inc. 10-Q

cvrs-10q093018.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001

Corindus Reports Third Quarter 2018 Results Advancing Development Programs for Remote Robotics and Neurovascular Applications

EX-99.1 2 ex99-1.htm PRESS RELEASE Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 For Immediate Release Corindus Reports Third Quarter 2018 Results Advancing Development Programs for Remote Robotics and Neurovascular Applications WALTHAM, Mass. - November 6, 2018 - Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today reported financia

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (

Corindus Vascular Robotics 8-K

Corindus Vascular Robotics 8-K Exhibit 99.1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) September 2018 Forward Looking Statements This presentation contains “forward - looking statements” (as such term is defined in Section 27 A of the Securities Act of 1933 , as amended, and Section 21 E of the Securities Exchange Act of 1934 , as amended), and information relating to the compan

Financial Statements and Exhibits, Other Events

cvrs-8k090518.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 5, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction

CORINDUS VASCULAR ROBOTICS, INC. $30,000,000 COMMON STOCK SALES AGREEMENT

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.1 CORINDUS VASCULAR ROBOTICS, INC. $30,000,000 COMMON STOCK SALES AGREEMENT August 31, 2018 Cowen and Company, LLC 599 Lexington Avenue New York, NY 10022 Ladies and Gentlemen: Corindus Vascular Robotics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: 1. Issuance and Sale of Shares.

Corporate Update

EX-99.1 4 ex99-1.htm CORPORATE UPDATE Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corporate Update An integral part of our growth strategy is to expand commercialization beyond the U.S. marketplace. Opportunities outside of the U.S. represent over 60% of the global procedure volume and are growing at a rate faster than the U.S. market. We intend to expand into and penetrate these new geograp

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (C

Supplemental Risk Factors

EX-99.2 5 ex99-2.htm SUPPLEMENTAL RISK FACTORS Corindus Vascular Robotics, Inc. 8-K Exhibit 99.2 Supplemental Risk Factors Risks Related to the Business Revenue related to our CorPath Cassettes is derived predominately from customers using our CorPath GRX System. If we do not receive repeat orders of CorPath Cassettes for use with the CorPath GRX System from our customers, our revenue may not grow

$30,000,000 Corindus Vascular Robotics, Inc. Common Stock

424B5 1 cvrs-424b5082818.htm PROSPECTUS Filed pursuant to Rule 424(b)(5) Registration No. 333-217344 PROSPECTUS SUPPLEMENT (To prospectus dated May 2, 2017) $30,000,000 Corindus Vascular Robotics, Inc. Common Stock We have entered into a sales agreement with Cowen and Company, LLC, or Cowen, relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectu

CORINDUS VASCULAR ROBOTICS, INC. S-8

As filed with the Securities and Exchange Commission on August 8, 2018 Registration No.

Certificate of Amendment of Certificate of Incorporation of Corindus Vascular Robotics, Inc. filed on May 31, 2018 with the State of Delaware Secretary of State*

Corindus Vascular Robotics, Inc. 10-Q Exhibit 3.1 Delaware The First State Page 1 I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF AMENDMENT OF “CORINDUS VASCULAR ROBOTICS, INC.”, FILED IN THIS OFFICE ON THE THIRTY-FIRST DAY OF MAY, A.D. 2018, AT 10:12 O’CLOCK A.M. A FILED COPY OF THIS CERTIFICATE HA

Corindus Vascular Robotics, Inc. 10-Q

10-Q 1 cvrs-10q063018.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

Corindus Vascular Robotics, Inc. 8-K

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.2 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) August 2018 Forward Looking Statements This presentation contains “forward - looking statements” (as such term is defined in Section 27 A of the Securities Act of 1933 , as amended, and Section 21 E of the Securities Exchange Act of 1934 , as amended), and information relating to the com

Corindus Reports Second Quarter 2018 Results Advancing Development Programs for Remote Robotics and Neurovascular Applications

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Reports Second Quarter 2018 Results Advancing Development Programs for Remote Robotics and Neurovascular Applications WALTHAM, MA – August 7, 2018 – Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today reported financial results for its second quarter ended June 30, 2018. Recent

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Co

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 15, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Com

Corindus Promotes Doug Teany to Chief Operating Officer

EX-99.1 2 ex99-1.htm PRESS RELEASE zCC CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 99.1 Corindus Promotes Doug Teany to Chief Operating Officer Waltham, MA. — JUNE 19, 2018 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it has appointed Douglas Teany, currently the company’s Senior Vice President of R&D and Operat

Financial Statements and Exhibits, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 31, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Comm

2018 Stock Award Plan*

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.1 2018 Stock Award Plan CORINDUS VASCULAR ROBOTICS, INC. 2018 Stock Award Plan 1. Purpose. The purpose of the Corindus Vascular Robotics, Inc. 2018 Stock Award Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby current and prospective directors, officers, employe

Corindus Vascular Robotics, Inc. 10-Q

10-Q 1 cvrs-10q033118.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Com

CVRS / Corindus Vascular Robotics, Inc. ADDITIONAL MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini

CVRS / Corindus Vascular Robotics, Inc. NOTIFICATION OF LATE FILING

SEC FILE NUMBER 001-37406 CUSIP NUMBER 218730 10 9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

CVRS / Corindus Vascular Robotics, Inc. ADDITIONAL MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Commi

Corindus Reports First Quarter 2018 Results

EX-99.1 2 ex99-1.htm PRESS RELEASE - CORINDUS REPORTS FIRST QUARTER 2018 RESULTS Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Reports First Quarter 2018 Results WALTHAM, MA – May 8, 2018 – Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2018. Recent Highl

CVRS / Corindus Vascular Robotics, Inc. DEFINITIVE PROXY STATEMENT

DEF 14A 1 cvrsdef14a-053118.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the

Corindus Vascular Robotics, Inc. 40,750,000 Shares of Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-224255 PROSPECTUS Corindus Vascular Robotics, Inc. 40,750,000 Shares of Common Stock This prospectus relates to the offering and resale by the selling stockholders identified herein, including their pledgees, donees, transferees, assigns or other successors-in-interest, of up to 40,750,000 shares of common stock of Corindus Vascular Robotics, I

CVRS / Corindus Vascular Robotics, Inc. CORRESP

Corindus Vascular Robotics, Inc. 309 Waverley Oaks Road, Suite 105 Waltham, MA 02452 April 18, 2018 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Corindus Vascular Robotics, Inc. Registration Statement on Form S-3 Filed Thursday, April 12, 2018 File No. 333-224255 Request for Acceleration Ladies and Gentleme

CVRS / Corindus Vascular Robotics, Inc. / SMITH ROBERT J - ACQUISITION OF BENEFICIAL OWNERSHIP Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a)) UNDER THE SECURITIES EXCHANGE ACT OF 1934 CORINDUS VASCULAR ROBOTICS, INC. (Name of Issuer) Common Stock, $0.0001 Par Value Per Share (Title of Class of Securities) 21873

CVRS / Corindus Vascular Robotics, Inc. PRELIMINARY PROXY STATEMENT

PRE 14A 1 cvrspre14a-053118.htm PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the

Corindus Vascular Robotics, Inc. S-3

As filed with the Securities and Exchange Commission on April 12, 2018 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Corindus Vascular Robotics, Inc. (Exact name of registrant as specified in its charter) Delaware EIN 30-0687898 (State of Incorporation) (IRS Employer Identification No.) 309 Waverley

Joint Filing Agreement

EX-99.1 Exhibit 99.1 Exhibit 1 Joint Filing Agreement The undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Issuer named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordanc

CVRS / Corindus Vascular Robotics, Inc. / Hudson Executive Capital LP - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

Loan and Security Agreement, dated March 16, 2018, by and among the Company and the parties named therein (the Revolving Loan Facility)

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.3 LOAN AND SECURITY AGREEMENT (REVOLVING LINE) THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of March 16, 2018 (the “Effective Date”) by and among (a) SILICON VALLEY BANK, a California corporation (“Bank”), and (b) (i) CORINDUS VASCULAR ROBOTICS, INC., a Delaware corporation (“Parent Borrower”) and (ii) CORINDUS, INC., a Delaware corpo

Loan and Security Agreement, dated March 16, 2018, by and among the Company and the parties named therein (the Term Loan Facility)

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.2 LOAN AND SECURITY AGREEMENT (TERM LOAN) THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of March 16, 2018 (the “Effective Date”) among (a) SILICON VALLEY BANK, a California corporation (“SVB”), as collateral agent (in such capacity, the “Collateral Agent”), (b) the lenders listed on Schedule 1.1 hereof or otherwise a party hereto from

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

8-K 1 cvrs-8k031618.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 EIN 30-0687898 (State

Form of Warrant to Purchase Stock

Corindus Vascular Robotics, Inc. 8-K Exhibit 4.1 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION

List of Subsidiaries of Corindus Vascular Robotics, Inc.*

EX-21 4 ex21.htm SUBSIDIARIES OF THE REGISTRANT Corindus Vascular Robotics, Inc. 10-K Exhibit 21 Subsidiaries of the registrant ● Corindus, Inc., a Delaware corporation and wholly-owned subsidiary ● Corindus Security Corporation, a Delaware corporation and wholly-owned subsidiary

Director Compensation Policy, as amended and restated effective December 15, 2017*

EX-10.25 2 ex10-25.htm DIRECTOR COMPENSATION POLICY Corindus Vascular Robotics, Inc. 10-K Exhibit 10.25 Corindus Vascular Robotics, Inc. Director Compensation Policy as Amended and Restated Effective December 15, 2017 I. Overview The Board of Directors (the “Board”) of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) has approved the following Director Compensation Policy (the “Polic

Corindus Vascular Robotics, Inc. 10-K

10-K 1 cvrs-10k123117.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37406 CORINDUS VASCULAR ROBOTICS, INC

Restricted Stock Unit Agreement*

Corindus Vascular Robotics, Inc. 10-K Exhibit 10.26 Restricted Stock Unit No. CORINDUS VASCULAR ROBOTICS, INC. Restricted Stock Unit Award Grant Notice Restricted Stock Unit Award Grant under the Company’s Amended and Restated 2014 Stock Award Plan 1. Name and Address of Participant: 2. Date of Grant of Restricted Stock Unit Award: 3. Maximum Number of Shares underlying Restricted Stock Unit Award

CVRS / Corindus Vascular Robotics, Inc. NOTICE OF RULE 12B25 OF INABILITY TO TIMELY FILE

SEC FILE NUMBER 001-37406 CUSIP NUMBER 218730 10 9 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 of Current Report on Form 8-K filed on March 16, 2018).

EX-3.1 2 ex3-1.htm FORM OF CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS Corindus Vascular Robotics, Inc. 8-K Exhibit 3.1 corindus vascular robotics, inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK AND SERIES A-1 CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersig

Form of Voting Agreement

EX-10.4 6 ex10-4.htm FORM OF VOTING AGREEMENT Corindus Vascular Robotics, Inc. 8-K Exhibit 10.4 Voting Agreement THIS VOTING AGREEMENT (this “Agreement”) is dated as of March , 2018 (the “Effective Date”), and is by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), the undersigned stockholders of the Company (each an “Existing Stockholder” and, collectively, the “

Form of Registration Rights Agreement

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of March , 2018, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto. This Agreement is made pursuant to the Securities Purchase Agreement (the “Purchase Agreement”), d

Securities Purchase Agreement dated March 15, 2018 by and among Corindus Vascular Robotics, Inc. and the investors named therein

EX-10.1 3 ex10-1.htm SECURITIES PURCHASE AGREEMENT Corindus Vascular Robotics, Inc. 8-K Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 16, 2018 by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and as

Form of Warrant

EX-10.3 5 ex10-3.htm FORM OF WARRANT Corindus Vascular Robotics, Inc. 8-K Exhibit 10.3 NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A)

Corindus Announces $25 Million Private Placement of Series A Convertible Preferred Shares and Warrants Douglas Braunstein to Join Board of Directors

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Announces $25 Million Private Placement of Series A Convertible Preferred Shares and Warrants Douglas Braunstein to Join Board of Directors WALTHAM, MA – March 16, 2018 – Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it has entered into definitive agreements

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

8-K 1 cvrs-8k031518.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001– 37406 EIN 30– 0687898 (Stat

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 cvrs-8k031318.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 13, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or O

James r. Tobin joins corindus board of directors

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.2 James r. Tobin joins corindus board of directors Waltham, MA. — MARCH 13, 2018 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that James (Jim) Tobin has been appointed to its Board of Directors, effective immediately. President and Chief Executive Officer Mark Toland sta

Corindus Reports Fourth Quarter and Full Year 2017 Results

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Reports Fourth Quarter and Full Year 2017 Results WALTHAM, MA – March 14, 2018 – Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today reported financial results for its fourth quarter and year ended December 31, 2017. Recent Highlights and Accomplishments ● Revenue of $4.2 millio

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 cvrs-8k030518.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of i

Corindus Receives FDA Clearance for CorPath® GRX System in Peripheral Vascular Interventions Expanded Indication Extends Robotic Precision to Broader Patient Base with Vascular Disease

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 99.1 Corindus Receives FDA Clearance for CorPath? GRX System in Peripheral Vascular Interventions Expanded Indication Extends Robotic Precision to Broader Patient Base with Vascular Disease Waltham, MA ? February 20, 2018 ? Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 20, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation)

Corindus Announces Preliminary Fourth Quarter and Full Year 2017 Revenue

EX-99.1 2 ex99-1.htm PRESS RELEASE Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Announces Preliminary Fourth Quarter and Full Year 2017 Revenue Waltham, MA – January 23, 2018 – Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today reported preliminary revenue results for the fourth quarter and year ended December 31, 2017. P

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 cvrs-8k012318.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 23, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or

Corindus Vascular Robotics, Inc. 8-K

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) January 2018 Forward Looking Statements This presentation contains ?forward - looking statements? (as such term is defined in Section 27 A of the Securities Act of 1933 , as amended, and Section 21 E of the Securities Exchange Act of 1934 , as amended), and information relating to the

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 8, 2018 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (C

Corindus Vascular Robotics, Inc. 8-K

EX-99.1 2 ex99-1.htm CORINDUS VASCULAR ROBOTICS, INC. INVESTOR PRESENTATION DATED NOVEMBER 2017 Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) November 2017 Forward Looking Statements This presentation contains “forward - looking statements” (as such term is defined in section 27 a of the securities act of 1933 , as amended, and se

CVRS / Corindus Vascular Robotics, Inc. CURRENT REPORT (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (

Corindus Vascular Robotics, Inc 10-Q

cvrs-10q093017.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001

Corindus Vascular Robotics Reports Third Quarter 2017 Results

Corindus Vascular Robotics 8-K Exhibit 99.1 Corindus Vascular Robotics Reports Third Quarter 2017 Results WALTHAM, MA – November 7, 2017 – Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today reported financial results for the quarter ended September 30, 2017. Recent Highlights and Accomplishments • Revenue of $2.4 million in the third q

Financial Statements and Exhibits, Results of Operations and Financial Condition

cvrs-8k080817.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 7, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction o

CVRS / Corindus Vascular Robotics, Inc. / KONINKLIJKE PHILIPS NV - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Secu

CORINDUS VASCULAR ROBOTICS, INC. S-8

cvrs-s8080917.htm As filed with the Securities and Exchange Commission on August 9, 2017 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 30-0687898 (State or other jurisdiction of incorporation

Corindus Vascular Robotics, Inc. 10-Q

10-Q 1 cvrs-10q063017.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

cvrs-8k080817.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of

Corindus Vascular Robotics Reports Second Quarter 2017 Results

ex99-1.htm Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Vascular Robotics Reports Second Quarter 2017 Results WALTHAM, MA ? August 8, 2017 ? Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today reported financial results for the quarter ended June 30, 2017. Recent Highlights and Accomplishments ? Revenue of $2.3 million in

JOHN K. BAKEWELL joins CORINDUS VASCULAR ROBOTICS BOARD OF DIRECTORS

EX-99.2 3 ex99-2.htm PRESS RELEASE Corindus Vascular Robotics, Inc. 8-K Exhibit 99.2 JOHN K. BAKEWELL joins CORINDUS VASCULAR ROBOTICS BOARD OF DIRECTORS Waltham, MA. — august 8, 2017 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that John K. Bakewell has been appointed to its board of directors, effective immediately.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 22, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Com

Amended and Restated 2014 Stock Award Plan, as amended on June 22, 2017*

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.1 APPENDIX A CORINDUS VASCULAR ROBOTICS, INC. Amended and Restated 2014 Stock Award Plan 1. Purpose. The purpose of the Corindus Vascular Robotics, Inc. Amended and Restated 2014 Stock Award Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby current and prospecti

Corindus Vascular Robotics DEFINITIVE PROXY STATEMENT

DEF 14A 1 cvrsdef14a-062217.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the

Corindus Vascular Robotics, Inc. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37406 CORINDUS VASCULA

Corindus Vascular Robotics Reports First Quarter 2017 Results Reiterates Financial Outlook for 2017

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 99.1 Corindus Vascular Robotics Reports First Quarter 2017 Results Reiterates Financial Outlook for 2017 WALTHAM, MA ? May 9, 2017 ? Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the quarter ended March 31, 2017. Recent Highlights and Accomplishments ? Realized

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Commi

Corindus Vascular Robotics, Inc. COMMON STOCK PREFERRED STOCK DEBT SECURITIES PURCHASE CONTRACTS

424B2 1 cvrs-424b2050217.htm PROSPECTUS Filed Pursuant to Rule 424(b)(2) Registration No. 333-217344 PRELIMINARY PROSPECTUS Corindus Vascular Robotics, Inc. $60,000,000 COMMON STOCK PREFERRED STOCK DEBT SECURITIES WARRANTS RIGHTS PURCHASE CONTRACTS UNITS This prospectus will allow us to issue, from time to time at prices and on terms to be determined at or prior to the time of the offering, up to

Corindus Vascular Robotics, Inc. 68,055,700 Shares of Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-217341 PROSPECTUS Corindus Vascular Robotics, Inc. 68,055,700 Shares of Common Stock This prospectus relates to the offering and resale by the selling stockholders identified herein, including their pledgees, donees, transferees, assigns or other successors-in-interest, of up to 68,055,700 shares of common stock, par value $0.0001 per share, of

Corindus Vascular Robotics ESP

Corindus Vascular Robotics, Inc. 309 Waverley Oaks Road, Suite 105 Waltham, MA 02452 April 27, 2017 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Corindus Vascular Robotics, Inc. Registration Statement on Form S-3 Filed Monday, April 17, 2017 File No. 333-217344 Request for Acceleration Ladies and Gentlemen:

Corindus Vascular Robotics ESP

Corindus Vascular Robotics, Inc. 309 Waverley Oaks Road, Suite 105 Waltham, MA 02452 April 27, 2017 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Corindus Vascular Robotics, Inc. Registration Statement on Form S-3 Filed Monday, April 17, 2017 File No. 333-217341 Request for Acceleration Ladies and Gentlemen:

Specimen Stock Certificate evidencing the shares of common stock filed herewith.

EX-4.2 2 ex4-2.htm SPECIMEN STOCK CERTIFICATE Corindus Vascular Robotics, Inc. S-3 Exhibit 4.2

Corindus Vascular Robotics, Inc. S-3

S-3 1 cvrs-s3041417.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on April 17, 2017 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Corindus Vascular Robotics, Inc. (Exact name of registrant as specified in its charter) Delaware EIN 30-0687898 (State of Incorporation)

Form of Senior Indenture

EX-4.2 3 ex4-2.htm FORM OF SENIOR INDENTURE Corindus Vascular Robotics, Inc. S-3 Exhibit 4.2 CORINDUS VASCULAR ROBOTICS, INC. Issuer AND [ ] Trustee INDENTURE Dated as of [ ] Senior Debt Securities CROSS-REFERENCE TABLE (1) Section of Trust Indenture Act Section of of 1939, as Amended Indenture 310(a). 7.09 310(b). 7.08 7.10 310(c). Inapplicable 311(a). 7.13(a) 311(b). 7.13(b) 311(c). Inapplicable

Specimen Stock Certificate evidencing the shares of common stock.

Corindus Vascular Robotics, Inc. S-3 Exhibit 4.1

Form of Subordinated Indenture

EX-4.3 4 ex4-3.htm FORM OF SUBORDINATED INDENTURE Corindus Vascular Robotics, Inc. S-3 Exhibit 4.3 CORINDUS VASCULAR ROBOTICS, INC. Issuer AND [ ] Trustee INDENTURE Dated as of [ ] Subordinated Debt Securities CROSS-REFERENCE TABLE (1) Section of Trust Indenture Act of 1939, as Amended Section of Indenture 310(a). 7.09 310(b). 7.08 7.10 310(c). Inapplicable 311(a). 7.13(a) 311(b). 7.13(b) 311(c).

Computation of Ratio of Earnings to Fixed Charges

CORINDUS VASCULAR ROBOTICS, INC. S-3 Exhibit 12.1 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES(1) The following table sets forth Corindus Vascular Robotics, Inc.’s ratio of earnings to fixed charges for the periods indicated. Fiscal year ended December 31, (dollars in thousands) 2016 2015 2014 2013 2012 Net loss from continuing operations $ (33,078 ) $ (28,763 ) $ (24,541 ) $ (14,691 ) $ (9,6

Corindus Vascular Robotics, Inc. S-3

As filed with the Securities and Exchange Commission on April 17, 2017 Registration No.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

8-K 1 cvrs-8k031517.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 EIN 30-0687898 (State

Corindus Vascular Robotics Announces Closing of Private Placement for $45 Million Louis A. Cannon, M.D. Appointed to Corindus Board of Directors

Corindus Vascular Robotics, Inc. 8K Exhibit 99.1 Corindus Vascular Robotics Announces Closing of Private Placement for $45 Million Louis A. Cannon, M.D. Appointed to Corindus Board of Directors WALTHAM, MA ? March 16, 2017 ? Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today announced the closing of its previously announced private placemen

CVRS / Corindus Vascular Robotics, Inc. / KONINKLIJKE PHILIPS NV - SC 13D/A Activist Investment

SC 13D/A 1 d337064dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Pe

Corindus Vascular Robotics Reports Fourth Quarter and Full Year 2016 Results Reiterates Financial Outlook for 2017 Announces 19 Purchase Orders for CorPath System Year to Date 2017

Corindus Vascular Robotics, Inc. - 8-K Exhibit 99.1 Corindus Vascular Robotics Reports Fourth Quarter and Full Year 2016 Results Reiterates Financial Outlook for 2017 Announces 19 Purchase Orders for CorPath System Year to Date 2017 WALTHAM, MA – March 15, 2017 – Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 15, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37406 CORINDUS VASCULAR ROBOTICS, INC. (Exact name of Registrant as specified

Subsidiaries of the Registrant*

Corindus Vascular Robotics, Inc. - 10-K Exhibit 21 Subsidiaries of the registrant ? Corindus, Inc., a Delaware corporation and wholly-owned subsidiary ? Corindus Security Corporation, a Delaware corporation and wholly-owned subsidiary

Registration Rights Agreement*

Corindus Vascular Robotics, Inc. - 10-K Exhibit 10.42 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is dated as of March 15, 2017, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the ?Company?), and the several signatories hereto. Recitals This Agreement is made pursuant to the Securities Purchase Agreement (the ?Purchase Agreement?), da

Corindus Vascular Robotics SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 218730109 (CUSIP Number) John F. Brown Hudson Executive Capital LP 1185 Avenue of the Americas, 32 nd Floor New York, NY 10036 With

CVRS / Corindus Vascular Robotics, Inc. / KONINKLIJKE PHILIPS NV - SC 13D Activist Investment

SC 13D 1 d267398dsc13d.htm SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Shar

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 8, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Com

Corindus Vascular Robotics, Inc. 8-K

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) March 2017 Forward Looking Statements THIS PRESENTATION CONTAINS ?FORWARD - LOOKING STATEMENTS? (AS SUCH TERM IS DEFINED IN SECTION 27 A OF THE SECURITIES ACT OF 1933 , AS AMENDED, AND SECTION 21 E OF THE SECURITIES EXCHANGE ACT OF 1934 , AS AMENDED), AND INFORMATION RELATING TO THE CO

Joint Filing Agreement

Exhibit 99 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, as of March 8, 2017, the undersigned each hereby agrees to the joint filing on behalf of each of them of a Statement on Schedule 13D, including amendments thereto (as amended, the “Schedule 13D”) with respect to common stock, par value $0.

CVRS / Corindus Vascular Robotics, Inc. / HealthCor Management, L.P. - SCHEDULE 13D Activist Investment

SC 13D 1 v461276sc13d.htm SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. ) Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 2187301

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 EIN 30-0687898 (State of Incorporation) (Commission File Numbe

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 cvrs-8k022417.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 EIN 30-0687898 (Sta

Securities Purchase Agreement, dated February 28, 2017, between the Company and certain purchasers, form of (incorporated herein by reference to Exhibit 10.1 to Corindus Vascular Robotics, Inc.’s Current Report on Form 8-K filed on March 1, 2017 (File No. 001-37406))

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 28, 2017, by and between Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and each Purchaser identified on Exhibit A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”

Corindus Vascular Robotics Announces Private Placement for $45 Million Financing Supports Launch Momentum of Next-Generation CorPath GRX System

EX-99.1 2 ex99-1.htm PRESS RELEASE Corindus Vascular Robotics, Inc. - 8-K Exhibit 99.1 Corindus Vascular Robotics Announces Private Placement for $45 Million Financing Supports Launch Momentum of Next-Generation CorPath GRX System WALTHAM, MA – February 28, 2017 – Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today that it has ente

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 EIN 30-0687898 (State of Incorporation) (Commission File N

CVRS / Corindus Vascular Robotics, Inc. / KONINKLIJKE PHILIPS NV - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 218730109 (CUSIP Number) December 31, 2015† (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu

Corindus Vascular Robotics Announces Strategic Distribution Partnership with MC Healthcare Group Granting Exclusive Rights to Distribute the CorPath® GRX System in Japan Includes the purchase of 12 CorPath GRX Systems with an Advance Payment of $2 Mi

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Vascular Robotics Announces Strategic Distribution Partnership with MC Healthcare Group Granting Exclusive Rights to Distribute the CorPath® GRX System in Japan Includes the purchase of 12 CorPath GRX Systems with an Advance Payment of $2 Million Waltham, MA – February X, 2017 – Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 EIN 30-0687898 (State of Incorporation) (Commission File N

CVRS / Corindus Vascular Robotics, Inc. / SMITH ROBERT J - SCHEDULE FILED TO REPORT ACQUISITION Passive Investment

SC 13G 1 cvrs-sc13g123116.htm SCHEDULE FILED TO REPORT ACQUISITION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* CORINDUS VASCULAR ROBOTICS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 218730 109 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the a

Corindus Vascular Robotics Announces Business Accomplishments for Fourth Quarter and Full Year 2016 and Updates 2017 Financial Guidance Conference Call Wednesday, January 18, at 8:00am ET

EX-99.1 2 ex99-1.htm PRESS RELEASE Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Vascular Robotics Announces Business Accomplishments for Fourth Quarter and Full Year 2016 and Updates 2017 Financial Guidance Conference Call Wednesday, January 18, at 8:00am ET Waltham, MA. — JANUARY 17, 2017 — Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 17, 2017 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (

CVRS / Corindus Vascular Robotics, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 218730109 (CUSIP Number) October 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w

Directors’ Compensation Policy 2016/2017 – As Amended and Restated Effective October 1, 2016

Corindus Vascular Robotics, Inc. 10-Q EXHIBIT 10.1 Directors’ Compensation Policy - 2016/17 as Amended and Restated Effective October 1, 2016 Overview The Board of Directors of Corindus Vascular Robotics, Inc. (the “Board”) has approved the following Director Compensation Policy (“Policy”) to provide an inducement to attract and retain the services of qualified persons to serve as directors. Eligi

Corindus Vascular Robotics, Inc. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37406 CORINDUS VAS

First Amendment to Commercial Lease

Corindus Vascular Robotics, Inc. 10-Q EXHIBIT 10.2 First Amendment to Commercial Lease The Parties hereto, Beaver Group LLC, (“LESSOR”) and Corindus, Inc. (“LESSEE”) are Parties under a certain Commercial Lease (“Lease Agreement”) dated October 24, 2012, for approximately 26,402 rentable square feet on the first floor at 309 Waverley Oaks Road, Suite 105, Waltham, MA and hereby agree as follows: W

Employment Agreement between Corindus Vascular Robotics, Inc. and Jeff Lemaster

Corindus Vascular Robotics, Inc. 10-Q EXHIBIT 10.3 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into on October 10, 2016 by and between Corindus Vascular Robotics, Inc., a Delaware corporation with its principal office in Waltham, Massachusetts (the “Company”), and Jeff Lemaster (the “Executive”). Any reference herein to “Corindus” shall mean Corindus, Inc., a wholl

Corindus Vascular Robotics Reports Third Quarter 2016 Results

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Vascular Robotics Reports Third Quarter 2016 Results WALTHAM, MA ? November 8, 2016 ? Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the three and nine month periods ended September 30, 2016. Recent Highlights and Accomplishments ? Realized revenue

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 8, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 8, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation)

Corindus Vascular Robotics, Inc. 8-K

Corindus Vascular Robotics, Inc. 8-K Ex 99.1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) September 2016 THIS PRESENTATION CONTAINS ?FORWARD - LOOKING STATEMENTS? (AS SUCH TERM IS DEFINED IN SECTION 27 A OF THE SECURITIES ACT OF 1933 , AS AMENDED, AND SECTION 21 E OF THE SECURITIES EXCHANGE ACT OF 1934 , AS AMENDED), AND INFORMATION RELATING TO THE COMPANY, THAT ARE BASED ON THE C

Corindus Vascular Robotics, Inc. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37406 CORINDUS VASCULAR

Corindus Vascular Robotics Reports Second Quarter 2016 Results

EX-99.1 2 ex99-1.htm PRESS RELEASE Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Vascular Robotics Reports Second Quarter 2016 Results WALTHAM, MA – August 4, 2016 – Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the three months ended June 30, 2016. Recent Highlights and Accomplishments · Rea

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 4, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Co

Plan of Conversion, dated as of June 23, 2016, (incorporated herein by reference to Exhibit No. 2.1 to Corindus Vascular Robotics, Inc.’s Current Report on Form 8-K filed on June 29, 2016 (File No. 001-37406))

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 2.1 PLAN OF CONVERSION THIS PLAN OF CONVERSION (this “Plan”) is adopted this 23rd day of June, 2016, by Corindus Vascular Robotics, Inc., a Nevada corporation (“Corindus-NV” or the “Company”), for the purpose of converting Corindus-NV into a Delaware corporation to be known as Corindus Vascular Robotics, Inc. (the “Resulting Entity”), in accordance with

Certificate of Incorporation, as filed with the Secretary of State of the state of Delaware (incorporated herein by reference to Exhibit 3.3 to Corindus Vascular Robotics, Inc.’s Current Report on Form 8-K filed on June 29, 2016 (File No. 001-37406))

EX-3.3 5 ex3-3.htm CERTIFICATE OF INCORPORATION CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 3.3 CERTIFICATE OF INCORPORATION OF CORINDUS VASCULAR ROBOTICS, INC. FIRST: The name of the corporation is Corindus Vascular Robotics, Inc. (hereinafter referred to as the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is 2140 South Dupont Highway,

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

8-K 1 cvrs-8k062316.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 23, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Othe

Certificate of Conversion, as filed with the Secretary of State of the State of Delaware on June 27, 2016

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 3.2

Amended and Restated Bylaws, effective June 28, 2016 (incorporated herein by reference to Exhibit No. 3.4 to Corindus Vascular Robotics, Inc.’s Current Report on Form 8-K filed on June 29, 2016 (File No. 001-37406))

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 3.4 CORINDUS VASCULAR ROBOTICS, INC. BYLAWS (effective June 28, 2016) ARTICLE I - STOCKHOLDERS Section 1. Annual Meeting. An annual meeting of the stockholders, for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting, shall be held at such place, on such dat

Articles of Conversion, as filed with the Secretary of State of the state of Nevada (incorporated herein by reference to Exhibit 3.1 to Corindus Vascular Robotics, Inc.’s Current Report on Form 8-K on June 29, 2016 (File No. 001-37406))

EX-3.1 3 ex3-1.htm ARTICLES OF CONVERSION CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 3.1

2014 Stock Award Plan, as amended and restated on June 23, 2016

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 10.1 CORINDUS VASCULAR ROBOTICS, INC. Amended and Restated 2014 Stock Award Plan 1. Purpose. The purpose of the Corindus Vascular Robotics, Inc. Amended and Restated 2014 Stock Award Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby current and prospective director

Corindus Vascular Robotics DEFINITIVE PROXY STATEMENT

DEF 14A 1 cvrs-def14a062316.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the

CORINDUS VASCULAR ROBOTICS, INC. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37406 CORINDUS VASCULA

Corindus Vascular Robotics Reports First Quarter 2016 Results

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Vascular Robotics Reports First Quarter 2016 Results WALTHAM, MA ? May 5, 2016 ? Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the three months ended March 31, 2016. Recent Highlights and Accomplishments ? Installed two new CorPath? Systems in the

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 cvrs-8k050516.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Other

Corindus Vascular Robotics PRELIMINARY PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

10,666,570 Shares of Common Stock

424B3 1 cvrs-424b3041916.htm PROSPECTUS Filed pursuant to Rule 424(b)(3) Registration No. 333-199498 PROSPECTUS 10,666,570 Shares of Common Stock This prospectus relates to the resale of up to 10,666,570 shares of common stock, par value $0.0001 per share, of Corindus Vascular Robotics, Inc., a Nevada corporation (the “Company”). The shares of common stock will be offered for resale by certain of

CVRS / Corindus Vascular Robotics, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 218730109 (CUSIP Number) March 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi

Corindus Vascular Robotics, Inc. POS AM

As filed with the Securities and Exchange Commission on April 5, 2016 Registration No.

Corindus Vascular Robotics, Inc. 10-K/A

10-K/A 1 cvrs-10ka123115.htm AMENDMENT TO FORM 10-K Privileged and Confidential UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA

Letter Agreement dated March 17, 2016 by and between the Company and Mr. Handler

Corindus Vascular Robotics, Inc. 8-K Exhibit 10.1 March 17, 2016 David Handler 619 Beacon Street Newton, MA 02459 Dear David: As we have discussed, pursuant to Section 5.1 of your Employment Agreement with Corindus Vascular Robotics, Inc. dated May 22, 2015 (the ?Employment Agreement?), you must execute this letter agreement (the ?Agreement?) in exchange for certain severance benefits to be provid

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 cvrs-8k031716.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 17, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Oth

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

10-K 1 cvrs-10k123115.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37406 CORINDUS VASCULAR ROBOTICS, INC

Subsidiaries of the Registrant

Corindus Vascular Robotics, Inc. 10-K Exhibit 21 Subsidiaries of the registrant ● Corindus, Inc., a Delaware corporation and wholly-owned subsidiary ● Corindus Security Corporation, a Delaware corporation and wholly-owned subsidiary

Corindus Vascular Robotics CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 8, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Commi

Corindus Vascular Robotics Reports Fourth Quarter and Year End 2015 Results

EX-99.1 2 ex99-1.htm PRESS RELEASE Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Vascular Robotics Reports Fourth Quarter and Year End 2015 Results WALTHAM, MA – March 8, 2016 – Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the three and twelve months ended December 31, 2015. Recent Highlight

CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock

424B3 1 cvrs-424b3022916.htm PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3) Registration No. 333-199498 PROSPECTUS SUPPLEMENT NO. 8 (to Prospectus dated April 21, 2015) CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock This prospectus supplement supplements and amends the prospectus dated April 21, 2015, relating to the resale by the selling stockholders named in the prosp

Corindus Appoints Mark J. Toland as President and Chief Executive Officer Toland Brings Over 20 Years of Healthcare Industry Operating Experience to Corindus

Corindus Vascular Robotics, Inc. 8-K Exhibit 99.1 Corindus Appoints Mark J. Toland as President and Chief Executive Officer Toland Brings Over 20 Years of Healthcare Industry Operating Experience to Corindus Waltham, MA - February 24, 2016 - Corindus Vascular Robotics, Inc. ("Corindus" or the "Company") [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today announced that Mark

Employment Agreement, dated February 23, 2016, between Corindus Vascular Robotics, Inc. and Mark J. Toland (incorporated herein by reference to Exhibit 99.2 to Corindus Vascular Robotics, Inc.’s Current Report on Form 8-K filed on February 26, 2016 (File No. 001-37406))

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (C

Corindus Vascular Robotics SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* CORINDUS VASCULAR ROBOTICS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 218730 109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul

CVRS / Corindus Vascular Robotics, Inc. / HealthCor Management, L.P. - SC 13G Passive Investment

SECURITIES & EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No.)* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock, $.0001 Par Value Per Share (Title of Class of Securities) 218730109 (CUSIP Number) December 31,

JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k)

EXHIBIT I JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements.

Corindus Vascular Robotics SEC SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares)

SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Corindus Vascular Robotics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 218730109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropria

CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-199498 PROSPECTUS SUPPLEMENT NO. 6 (to Prospectus dated April 21, 2015) CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock This prospectus supplement supplements and amends the prospectus dated April 21, 2015, relating to the resale by the selling stockholders named in the prospectus (the ?Selling Stockholders?) of up to 10,666,

CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-199498 PROSPECTUS SUPPLEMENT NO. 7 (to Prospectus dated April 21, 2015) CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock This prospectus supplement supplements and amends the prospectus dated April 21, 2015, relating to the resale by the selling stockholders named in the prospectus (the ?Selling Stockholders?) of up to 10,666,

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 4, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation) (Co

CORINDUS Appoints CamPBELL ROGERS, m.d. to its Board of Directors

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 99.1 CORINDUS Appoints CamPBELL ROGERS, m.d. to its Board of Directors Waltham, MA.—FEBRUARY 8, 2016—Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS] today announced that Campbell Rogers, M.D. has been appointed to its Board of Directors, effective immediately. Dr. Rogers is a veteran in the medical technology industry and healthcare field with over 30

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 cvrs-8k012816.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 28, 2016 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or O

INDEMNIFICATION AGREEMENT

CORINDUS VASCULAR ROBOTICS, INC. 8-K Exhibit 99.1 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this ?Agreement?) is made and entered into this day of , 201, by and between Corindus Vascular Robotics, Inc., a Nevada corporation (the ?Company?), and (?Indemnitee?). WHEREAS, qualified persons are reluctant to serve corporations as directors, officers or otherwise unless they are provided

CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock

424B3 1 d10997d424b3.htm 424B3 Table of Contents Filed pursuant to Rule 424(b)(3) Registration No. 333-199498 PROSPECTUS SUPPLEMENT NO. 5 (to Prospectus dated April 21, 2015) CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock This prospectus supplement supplements and amends the prospectus dated April 21, 2015, relating to the resale by the selling stockholders named in the prospec

Corindus Vascular Robotics FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 17, 2015 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Other Jurisdiction of Incorpor

FORWARD LOOKING STATEMENTS THIS PRESENTATION CONTAINS “FORWARD-LOOKING STATEMENTS” (AS SUCH TERM IS DEFINED IN SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AND INFORMATION

EX-99.1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) Overview November 2015 Exhibit 99.1 FORWARD LOOKING STATEMENTS THIS PRESENTATION CONTAINS “FORWARD-LOOKING STATEMENTS” (AS SUCH TERM IS DEFINED IN SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AND INFORMATION RELATING TO THE COMPANY, THAT ARE BASED ON T

Corindus Vascular Robotics Reports Third Quarter 2015 Results

EX-99.1 Exhibit 99.1 Corindus Vascular Robotics Reports Third Quarter 2015 Results WALTHAM, MA ? November 12, 2015 ? Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the three and nine months ended September 30, 2015. Recent Highlights and Accomplishments ? Installed two new CorPath? systems increasing the t

AMENDED AND RESTATED YOUR INTERNET DEFENDER INC.CORINDUS VASCULAR ROBOTICS, INC. (the “Corporation”) * * * * * * * * * * * ARTICLE I

Exhibit 3.2b AMENDED AND RESTATED BY - LAWS OF YOUR INTERNET DEFENDER INC. CORINDUS VASCULAR ROBOTICS, INC. (the ?Corporation?) * * * * * * * * * * * ARTICLE I Offices The Corporation may have offices at such other places, both within and without the State of Nevada, as the Board of Directors may determine and designate from time to time or the business of the Corporation requires. ARTICLE II Book

AMENDED AND RESTATED CORINDUS VASCULAR ROBOTICS, INC. (the “Corporation”) * * * * * * * * * * * ARTICLE I

Exhibit 3.2a AMENDED AND RESTATED BYLAWS OF CORINDUS VASCULAR ROBOTICS, INC. (the “Corporation”) * * * * * * * * * * * ARTICLE I Offices The Corporation may have offices at such other places, both within and without the State of Nevada, as the Board of Directors may determine and designate from time to time or the business of the Corporation requires. ARTICLE II Books The books and records of the

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 12, 2015 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-

Regulation FD Disclosure, Financial Statements and Exhibits

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 25, 2015 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 001-37406 30-0687898 (State or Other Jurisdiction of Incorporation)

Precision Vascular Robotics

EX-99.1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) Overview August 2015 Exhibit 99.1 FORWARD LOOKING STATEMENTS THIS PRESENTATION CONTAINS ?FORWARD-LOOKING STATEMENTS? (AS SUCH TERM IS DEFINED IN SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AND INFORMATION RELATING TO THE COMPANY, THAT ARE BASED ON THE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37406

Corindus Vascular Robotics FORM S-8

FORM S-8 As filed with the Securities and Exchange Commission on August 13, 2015 Registration No.

CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock

424B3 Table of Contents Filed pursuant to Rule 424(b)(3) Registration No. 333-199498 PROSPECTUS SUPPLEMENT NO. 4 (to Prospectus dated April 21, 2015) CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock This prospectus supplement supplements and amends the prospectus dated April 21, 2015, relating to the resale by the selling stockholders named in the prospectus (the ?Selling Stockho

CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock

424b3 Filed pursuant to Rule 424(b)(3) Registration No. 333-199498 PROSPECTUS SUPPLEMENT NO. 3 (to Prospectus dated April 21, 2015) CORINDUS VASCULAR ROBOTICS, INC. 10,666,570 Shares of Common Stock This prospectus supplement supplements and amends the prospectus dated April 21, 2015, relating to the resale by the selling stockholders named in the prospectus (the “Selling Stockholders”) of up to 1

Corindus Vascular Robotics FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2015 CORINDUS VASCULAR ROBOTICS, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 333-176581 30-0687898 (State or Other Jurisdiction of Incorporatio

Corindus Vascular Robotics Announces Pricing of Public Offering of Common Stock

EX-99.1 Exhibit 99.1 For Immediate Release Corindus Vascular Robotics Announces Pricing of Public Offering of Common Stock Waltham, MA – May 28, 2015 – Corindus Vascular Robotics, Inc. (OTCQB: CVRS), a leading developer of precision vascular robotics, today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock at a public offering price of $3.80 per shar

11,000,000 Shares Common Stock

424B4 Table of Contents Filed pursuant to Rule 424(b)(4) Registration Statement No.